Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development

Molecular and Cellular Biology

Volumn 25, Issue 5, 2005, Pages 1980-1988

  Jakupoglu, Cemile ^a,c   Przemeck, Gerhard K H ^a   Schneider, Manuela ^a   Moreno, Stéphanie G ^a   Mayr, Nadja ^a   Hatzopoulos, Antonis K ^a   De Angelis, Martin Hrabé ^a   Wurst, Wolfgang ^a,b   Bornkamm, Georg W ^a   Brielmeier, Markus ^a   Conrad, Marcus ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYTOPLASM PROTEIN; MITOCHONDRIAL PROTEIN; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EMBRYO CELL; EMBRYO CULTURE; EMBRYO DEVELOPMENT; ENZYME DEFICIENCY; ENZYME INACTIVATION; EX VIVO STUDY; FIBROBLAST; GENE DELETION; GROWTH RETARDATION; HEART DEVELOPMENT; HEART MUSCLE CELL; HOMOZYGOTE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LETHALITY; MITOCHONDRION; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CYTOPLASM; EMBRYO; EMBRYONIC DEVELOPMENT; GENE EXPRESSION; GENE TARGETING; HEART; MICE; MYOCARDIUM; RNA, MESSENGER; THIOREDOXIN REDUCTASE (NADPH);

EID: 20044378664     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.5.1980-1988.2005     Document Type: Article

References (48)

1. Andersson, M., A. Holmgren, and G. Spyrou. 1996. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J. Biol. Chem. 271:10116-10120.
2. Anestal, K., and E. S. Arner. 2003. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J. Biol. Chem. 278:15966-15972.
3. Arner, E. S., and A. Holmgren. 2000. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267:6102-6109.
4. Conrad, M., M. Brielmeier, W. Wurst, and G. W. Bornkamm. 2003. Optimized vector for conditional gene targeting in mouse embryonic stem cells. BioTechniques 34:1136-1138, 1140.
5. Conrad, M., C. Jakupoglu, S. G. Moreno, S. Lippl, A. Banjac, M. Schneider, H. Beck, A. K. Hatzopoulos, U. Just, F. Sinowatz, W. Schmahl, K. R. Chien, W. Wurst, G. W. Bornkamm, and M. Brielmeier. 2004. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol. Cell. Biol. 24:9414-9423.
6. Crosio, C., G. M. Fimia, R. Loury, M. Kirnura, Y. Okano, H. Zhou, S. Sen, C. D. Allis, and P. Sassone-Corsi. 2002. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22:874-885.
7. Fujiwara, N., T. Fujii, J. Fujii, and N. Taniguchi. 1999. Functional expression of rat thioredoxin reductase: selenocysteine insertion sequence element is essential for the active enzyme. Biochem. J. 340:439-444.
8. Gasdaska, J. R., J. W. Harney, P. Y. Gasdaska, G. Powis, and M. J. Berry. 1999. Regulation of human thioredoxin reductase expression and activity by 3′-untranslated region selenocysteine insertion sequence and mRNA instability elements. J. Biol. Chem. 274:25379-25385.
9. Gasdaska, P. Y., M. M. Berggren, M. J. Berry, and G. Powis. 1999. Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett. 442:105-111.
10. Gladyshev, V. N., K. T. Jeang, and T. C. Stadtman. 1996. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA 93:6146-6151.
11. Gorlatov, S. N., and T. C. Stadtman. 1998. Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Proc. Natl. Acad. Sci. USA 95:8520-8525.
12. Gromer, S., J. Wissing, D. Behne, K. Ashman, R. H. Schirmer, L. Flohe, and K. Becker. 1998. A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem. J. 332:591-592.
13. Han, H., D. J. Bearss, L. W. Browne, R. Calaluce, R. B. Nagle, and D. D. Von Hoff. 2002. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 62:2890-2896.
14. Hartman, H., M. Wu, B. B. Buchanan, and J. C. Gerhart. 1993. Spinach thioredoxin m inhibits DNA synthesis in fertilized Xenopus eggs. Proc. Natl. Acad. Sci. USA 90:2271-2275.
15. Herrmann, B. G. 1991. Expression pattern of the Brachyury gene in whole-mount TWis/TWis mutant embryos. Development 113:913-917.
16. Hirota, K., H. Nakamura, H. Masutani, and J. Yodoi. 2002. Thioredoxin superfamily and thioredoxin-inducing agents. Ann. N. Y. Acad. Sci. 957:189-199.
17. Hogan, B., C. F. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
18. Joyner, S. 1999. Gene targeting - a practical approach, 2nd ed. Institute of Biomolecular Medicine, NYU Medical Centre, New York, N.Y.
19. Jurado, J., M. J. Prieto-Alamo, J. Madrid-Risquez, and C. Pueyo. 2003. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J. Biol. Chem. 278:45546-45554.
20. Karimpour, S., J. Lou, L. L. Lin, L. M. Rene, L. Lagunas, X. Ma, S. Karra, C. M. Bradbury, S. Markovina, P. C. Goswami, D. R. Spitz, K. Hirota, D. V. Kalvakolanu, J. Yodoi, and D. Gius. 2002. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 21:6317-6327.
21. Laurent, T. C., E. C. Moore, and P. Reichard. 1964. Enzymatic synthesis of Deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem. 239:3436-3444.
22. Lee, S. R., S. Bar-Noy, J. Kwon, R. L. Levine, T. C. Stadtman, and S. G. Rhee. 2000. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc. Natl. Acad. Sci. USA 97:2521-2526.
23. Lincoln, D. T., E. M. Ali Emadi, K. F. Tonissen, and F. M. Clarke. 2003. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 23:2425-2433.
24. Matsui, M., M. Oshima, H. Oshima, K. Takaku, T. Maruyama, J. Yodoi, and M. M. Taketo. 1996. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev. Biol. 178:179-185.
25. Muller, E. G. 1991. Thioredoxin deficiency in yeast prolongs S phase and shortens the G1 interval of the cell cycle. J. Biol. Chem. 266:9194-9202.
26. Mustacich, D., and G. Powis. 2000. Thioredoxin reductase. Biochem. J. 346:1-8.
27. Nalvarte, I., A. E. Damdimopoulos, C. Nystrom, T. Nordman, A. Miranda-Vizuete, J. M. Olsson, L. Eriksson, M. Bjornstedt, E. S. Arner, and G. Spyrou. 2004. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells: effect on cell growth and differentiation. J. Biol. Chem. 279:54510-54517.
28. Nalvarte, I., A. E. Damdimopoulos, and G. Spyrou. 2004. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition. Free Radic. Biol. Med. 36:1270-1278.
29. Nishinaka, Y., H. Nakamura, and J. Yodoi. 2002. Thioredoxin cytokine action. Methods Enzymol. 347:332-338.
30. Nonn, L., R. R. Williams, R. P. Erickson, and G. Powis. 2003. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23:916-922.
31. Nordberg, J., and E. S. Arner. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31:1287-1312.
32. Pekkari, K., and A. Holmgren. 2004. Truncated thioredoxin: physiological functions and mechanism. Antioxid. Redox Signal. 6:53-61.
33. Powis, G., D. Mustacich, and A. Coon. 2000. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29:312-322.
34. Qin, J., G. M. Clore, W. M. Kennedy, J. R. Huth, and A, M. Gronenborn. 1995. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure 3:289-297.
35. Rhee, S. G., S. W. Kang, T. S. Chang, W. Jeong, and K. Kim. 2001. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52:35-41.
36. Rundlof, A. K., and E. S. Arner. 2004. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid. Redox Signal. 6:41-52.
37. Rundlof, A. K., M. Janard, A. Miranda-Vimete, and E. S. Arner. 2004. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic. Biol. Med. 36:641-656.
38. RZPD. http://www.rzpd.de.
39. Schuhmacher, M., F. Kohlhuber, M. Holzel, C. Kaiser, H. Burtscher, M. Jarsch, G. W. Bornkamm, G. Laux, A. Polack, U. H. Weidle, and D. Eick. 2001. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29:397-406.
40. Sporle, R., and K. Schughart. 1998. Paradox segmentation along inter- and intrasomitic borderlines is followed by dysmorphology of the axial skeleton in the open brain (opb) mouse mutant. Dev. Genet. 22:359-373.
41. Sun, Q. A., L. Kirnarsky, S. Sherman, and V. N. Gladyshev. 2001. Seleno-protein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc. Natl. Acad. Sci. USA 98:3673-3678.
42. Sun, Q. A., F. Zappacosta, V. M. Factor, P. J. Wirth, D. L. Hatfield, and V. N. Gladyshev. 2001. Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J. Biol. Chem. 276:3106-3114.
43. Wei, Y., C. A. Mizzen, R. G. Cook, M. A. Gorovsky, and C. D. Allis. 1998. Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena. Proc. Natl. Acad. Sci. USA 95:7480-7484.
44. Wettschureck, N., H. Rutten, A. Zywietz, D. Gehring, T. M. Wilkie, J. Chen, K. R. Chien, and S. Offermanns. 2001. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat. Med. 7:1236-1240.
45. Xia, L., T. Nordman, J. M. Olsson, A. Damdimopoulos, L. Bjorkhem-Bergman, I. Nalvarte, L. C. Eriksson, E. S. Arner, G. Spyrou, and M. Bjornstedt. 2003. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J. Biol. Chem. 278:2141-2146.
46. Yamamoto, M., G. Yang, C. Hong, J. Liu, E. Holle, X. Yu, T. Wagner, S. F. Vatner, and J. Sadoshima. 2003. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J. Clin. Investig. 112:1395-1406.
47. Yamawaki, H., J. Haendeler, and B. C. Berk. 2003. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ. Res. 93:1029-1033.
48. Zhong, L., and A. Holmgren. 2000. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J. Biol. Chem. 275:18121-18128.